02 June 2026 : Clinical Research
Ciprofol-Esketamine Versus Ciprofol-Remifentanil in Hysteroscopic Endometrial Polypectomy: A Randomized Controlled Trial
Zhong Zhang ABC 1, Zhixu Wang BC 1, Wanwan Gong DEF 1, Wei Jiang AF 1*, Longjiao Zheng DEF 1, Zhiyang Yu AEF 1DOI: 10.12659/MSM.952468
Med Sci Monit 2026; 32:e952468
Table 4 Satisfaction (visual analogue scale, 0–10) and postprocedural assessments.
| Variable | CK (n=60) | CR (n=60) | χ2/t | P |
|---|---|---|---|---|
| Satisfaction with sedation | ||||
| Gynecologists | 8.9±1.1 | 8.7±0.8 | −0.997 | 0.321 |
| Anesthesiologists | 8.8±0.8 | 8.5±0.7 | −1.549 | 0.124 |
| Postoperative VAS score | ||||
| 10 min | 2.2±0.7 | 2.9±0.9 | 4.780 | <0.001 |
| 30 min | 1.9±0.5 | 1.9±0.6 | −0.149 | 0.882 |
| 6 h | 2.7±0.6 | 2.6±0.7 | 0.541 | 0.590 |
| CK – ciprofol-esketamine regimen; CR – ciprofol-remifentanil regimen; VAS – visual analog scale. | ||||